Funding for this research was provided by:
British Heart Foundation (CS/16/4/32482)
National Institutes of Health (R01 DK10324)
FP7 Ideas: European Research Council (669545)
Horizon 2020 (733206)
Wellcome Trust (WT101597MA)
Medical Research Council (MC_UU_12013/5, MR/K021656/1, MR/N024397/1)
National Institute for Health Research (NF-SI-0611-10196)
Received: 15 December 2017
Accepted: 10 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: The research was approved by the Bradford National Health Service Research Ethics Committee (ref 06/Q1202/48). All participants gave written informed consent.
: Not applicable.
: D.A. Lawlor has received support from Medtronic and Roche Diagnostics for biomarker research unrelated to the research presented in this paper. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.